BSEInsider Trading / SAST8 Oct 2026 · 8 Oct 2026, 04:34 pm

The Revised Intimation for Closure of Trading Window for declaration of financial results for the period ended 30th September, 2026, due to subsequent change in decision of management has been attached herewith.

Dharti Proteins Ltd · 531171

✦ AI SummaryBonus/Split

Dharti Proteins Ltd has revised its intimation for closure of trading window due to a change in management's decision to consider a bonus issue. The trading window will remain closed till 48 hours after the declaration of audited financial results for the quarter and half year ending on 30th September, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Dharti Proteins Ltd - 531171 - Closure of Trading Window

Attachments (1)

📄

62a69393-a67a-4798-9a6c-25951edfa90c.pdf

pdf

Download →
View document text
08th October, 2026 The General Manager, Listing Department, BSE Limited Pheeroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400001, Maharashtra India Symbol: DHARTI ISIN: INE248C01021 Scrip Code: 531171 Dear Sir/Madam, Subject: Revised Intimation – Closure of Trading Window Ref: Intimation dated September 23, 2026 regarding Closure of Trading Window Dear Sir/Madam, This is with reference to the intimation submitted by the Company regarding closure of the Trading Window pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015. We wish to inform you that, pursuant to a subsequent decision of the management of the Company to consider the issuance of Bonus Shares out of the audited free reserves or Securities Premium or Capital Redemption Reserves, if any, of the Company, it has been decided that the financial results for the Quarter and Half Year ending on 30th September, 2026 shall be considered and adopted as Audited Financial Results for the purpose of determining the availability of audited free reserves or Securities Premium or Capital Redemption Reserves, if any, and other relevant financial parameters in connection with the proposed Bonus Issue. Accordingly, the relevant portion of the earlier intimation regarding closure of the Trading Window shall be read as under: “...the Trading Window for dealing in Equity Shares of the Company by all the Directors, Promoters, Designated Persons and Specified Connected Persons of the Company as covered under Company's Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities is being closed from Thursday, 01st October, 2026 and will remain closed till 48 hours after the declaration of the Audited Financial Results for the Quarter and Half Year ending on 30th September, 2026.” Further, wherever the expression “Unaudited Financial Results” appears in the earlier intimation, the same shall be read as “Audited Financial Results.” The aforesaid change is being made to give effect to the subsequent decision of the management of the Company to consider the proposed Bonus Issue out of the audited free reserves of the Company and does not otherwise affect the closure of the Trading Window or the period for which the Trading Window shall remain closed. All other contents of the earlier intimation shall remain unchanged. We request you to kindly take the above revised intimation on record and oblige. Yours Faithfully, For DHARTI PROTEINS LIMITED (Formerly Devika Proteins Limited) Twinkle Bipinchandra Gajjar Company Secretary and Compliance Officer ICSI Membership No. A77101